MRSA

MRSA is presently a pathogen of global health concern. . They are S. aureus strains that are resistant to oxacillin, nafcillin and methicillin. They can also be resistant to all ß-lactam agents. It can cause a variety of problems ranging from skin infections and sepsis to pneumonia and various types of bloodstream infections. The infections occur commonly among people in hospitals and healthcare facilities such as nursing homes, diagnostic centres and dialysis centres, who have less stable immune systems. The current arsenal of antibiotics available for the treatment of MRSA includes a topical agent, a limited number of oral agents.

  • Community-acquired MRSA (CA-MRSA)
  • Healthcare-associated MRSA (HA-MRSA)
  • Virulence Associated Factors of CA-MRSA
  • Antibiotic resistance
  • Recurrent MRSA Infections
  • Oral and intravenous agents
  • Topical agents
  • Vancomycin, Clindamycin and linezolid
  • Pneumonia (HAP/VAP)
  • Chronic osteomyelitis (COM)
  • Skin and soft tissue infections

    Related Conference of MRSA

    October 24-25, 2022

    17th World Congress on Virology, Emerging Diseases & Vaccines

    Zurich, Switzerland
    November 08-09, 2022

    7th Rare Diseases and Orphan Drugs

    London, UK
    November 21-22, 2022

    World Summit on Rare Disease

    Rome, Italy
    December 12-13, 2022

    5th Pathology and Infectious Disease Conference

    Prague, Czech Republic
    January 23-24, 2023

    10th International Congress on Infectious Diseases

    Barcelona, Spain
    February 20-21, 2023

    6th International Conference on Rare Diseases

    Amsterdam, Netherlands
    August 08-09, 2023

    19th World Congress on Infection Prevention and Control

    Zurich, Switzerland
    September 27-28, 2023

    32nd International Conference on Coronary Diseases

    Zurich, Switzerland

    MRSA Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in